Bolt Biotherapeutics

Scroll
Investment area
Novo Ventures
Date of investment
September 2016

Bolt Biotherapeutics is developing its novel BoltbodyTM platform for cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC)